«Talented graduate students are a creative and energetic force that will contribute to the kind of innovation required
for progress against cancer and other life - threatening diseases.
Not exact matches
Phase I / II clinical trial results reported at the American Society
for Clinical Oncology (ASCO) Annual Meeting 2015 show promising results
for investigational drug brigatinib
against ALK + non-small cell lung
cancer (NSCLC), with 58 of 78 ALK + patients responding to treatment, including 50 of 70 patients who had
progressed after previous treatment with crizotinib, the first licensed ALK inhibitor.
The researchers didn't comment on whether this discovery could lead to
progress against the disease, but past research has looked to Fgfr as a target
for cancer treatments and found it promising.
Vaccine research has been heralded as a bright spot in 2012's medical advances
against cancer and related diseases — with potential
for yielding even more
progress in 2013.
Research led by UNC Lineberger Comprehensive
Cancer Center members Katherine Hoadley, PhD, research assistant professor in genetics and Chuck Perou, PhD, professor of genetics and pathology, was selected by the American Society of Clinical Oncology for inclusion in Clinical Cancer Advances 2015, the Society's annual review of progress against cancer and emerging trends in the
Cancer Center members Katherine Hoadley, PhD, research assistant professor in genetics and Chuck Perou, PhD, professor of genetics and pathology, was selected by the American Society of Clinical Oncology
for inclusion in Clinical
Cancer Advances 2015, the Society's annual review of progress against cancer and emerging trends in the
Cancer Advances 2015, the Society's annual review of
progress against cancer and emerging trends in the
cancer and emerging trends in the field.
Cancer Research UK and the American Association for Cancer Research (AACR) are launching an international alliance to speed the pace of progress against c
Cancer Research UK and the American Association
for Cancer Research (AACR) are launching an international alliance to speed the pace of progress against c
Cancer Research (AACR) are launching an international alliance to speed the pace of
progress against cancercancer.
Second, within the field of pediatric oncology, they represent five critical areas in which clinical research success must occur
for continued
progress against childhood
cancer to be realized.